Nisa Investment Advisors
CMPX icon

Nisa Investment Advisors’s Compass Therapeutics CMPX Stock Holding History

Nisa Investment Advisors’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.8K Hold
5,248
– – ﹤0.01% 1894
2025
Q4 		$28.2K Hold
5,248
– – ﹤0.01% 1813
2025
Q3 		$18.4K Hold
5,248
– – ﹤0.01% 2043
2025
Q2 		$13.6K Buy
5,248
+4,400
+519% +$9.07K ﹤0.01% 2114
2025
Q1 		$1.61K Hold
848
– – ﹤0.01% 2525
2024
Q4 		$1.23K Buy
848
+419
+98% +$696 ﹤0.01% 2625
2024
Q3 		$789 Sell
429
-172
-29% -$214 ﹤0.01% 2628
2024
Q2 		$601 Buy
601
+581
+2,905% +$849 ﹤0.01% 2646
2024
Q1 		$40 Sell
20
-45
-69% -$78 ﹤0.01% 2756
2023
Q4 		$101 Buy
+65
New +$112 ﹤0.01% 2613

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Nisa Investment Advisors's CMPX Position: Q1 2026 in Review

Nisa Investment Advisors held its Compass Therapeutics (CMPX) position steady in Q1 2026 at 5,248 shares worth $27.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1894.

Nisa Investment Advisors first reported a position in CMPX in Q4 2023 and has held it in 10 quarters since. The position peaked at $28.2K in Q4 2025. 201 funds tracked by Wall St. Rank hold CMPX as of Q1 2026.

  • Nisa Investment Advisors held 5,248 shares of Compass Therapeutics worth $27.8K as of Q1 2026.
  • Nisa Investment Advisors left its Compass Therapeutics share count unchanged in Q1 2026.
  • Compass Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #1894 holding.
  • Nisa Investment Advisors first reported a position in Compass Therapeutics in Q4 2023 and has held it in 10 quarters since.
  • Nisa Investment Advisors's Compass Therapeutics position peaked at $28.2K in Q4 2025.
  • 201 funds tracked by Wall St. Rank held Compass Therapeutics as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.